Pharmafile Logo
Pharmafocus logo
Advanced Search

Otsuka

Showing 11 posts of 26 posts found.

Avanir image

Otsuka buys Avanir for $3.5 billion

December 3, 2014
Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir

Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …

News

FDA accepts new schizophrenia drug filing

September 24, 2014
Sales and Marketing FDA, Lundbeck, Otsuka, brexpiprazole, depression, schizophrenia

The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …

News
Dieter Weinand image

Bayer announces more changes at the top

June 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Dieter Weinand, Otsuka, dekkers, healthcare

US-based president at Japanese drugmaker Otsuka, Dieter Weinand, is to join Bayer Healthcare Pharmaceuticals as the new head of its …

News
Otsuka image

Otsuka buys Astex for $866 million

September 6, 2013
Sales and Marketing Astex, Lundbeck, Onyx, Otsuka

Otsuka Pharmaceutical is to buy UK-based Astex Pharmaceuticals in a deal that will see the Tokyo-based firm shelling out $866 …

News
lundbeck image

Lundbeck/Otsuka Alzheimer’s drug improves cognition

July 17, 2013
Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …

News
Abilify image

NICE thumbs-up for Abilify

June 7, 2013
Sales and Marketing Abilify, BMS, NICE, Otsuka

Adolescents who suffer from bipolar disorder should be treated on the NHS with Otsuka Pharmaceuticals’ Abilify, according to draft guidance …

News

Lundbeck moves ahead in Q1

May 3, 2013
Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1

Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …

News

Otsuka and UCB scale down collaboration

January 16, 2012
Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB

Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …

News

Lundbeck and Otsuka to collaborate in CNS

November 11, 2011
Research and Development, Sales and Marketing Abilify, CNS, Lundbeck, Otsuka

Lundbeck and Otsuka have signed a major collaborative deal to sell and develop up to five CNS drugs, including a …

News

NICE decides to back Abilify in schizophrenia

January 27, 2011
Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia

NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …

News

Working Life: Ali Ross

September 25, 2008
Medical Communications, Sales and Marketing Europe, Otsuka, communications

How did you find your way into this role?

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026